ADDITIONAL DETAILS REQUIRED FOR CORPORATE ANNOUNCEMENT UNDER REGULATION 30
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Brawn Biotech Ltd has informed BSE that Mrs. Brij Bala Gupta (DIN: 00975261) resigned from the Board of Directors with effect from 25 November 2025, citing pre-occupation and unavoidable circumstances. The filing was made to furnish additional details sought by BSE under Regulation 30 of SEBI LODR read with the November 2024 SEBI circular. Mrs. Gupta was not a member of any board committee. The company confirmed there are no other material reasons for her resignation beyond what is stated in her letter. The resignation was signed by the Company Secretary, Priyanka Sharma.
A single non-executive director exiting over personal reasons is a routine disclosure and unlikely to materially affect the stock price, though shareholders may note the change in board composition. No governance concerns or financial irregularities have been flagged.